The fundamental role of TP53 is evident in Li-Fraumeni syndrome which is characterized by germline mutations of TP53 and predisposition to aggressive tumors like early-onset breast cancer (25%), soft-tissue or bone sarcomas (35%) and brain tumors. Here, TP53 is linked to aggressive behavior.